Aditya Birla Sun Life Flexi Cap Fund Regular-Growth
The fund is rated 2 stars. Balance between returns and downside risk was a strength, while investment selection within each industry provided some support. Investment selection within each asset type was the main limitation and did not provide enough support for a higher rating. Above-average fund size of Rs 29,044.24 crore was a minor drawback.
This fund has a bad track record with Asset Selection/Timing, a ok track record with Stock Selection/Timing, a good risk-reward ratio. It is important to note, however, that this fund has a 29044.244 AUM and a 1.66 expense ratio. Considering all these factors, we have rated this fund as 2.0 star.
અમારો સ્કોર લાંબા ગાળાની કામગીરી, જોખમ અને સાતત્યને વજન આપે છે — ફક્ત ભૂતકાળના વળતરને નહીં.
રિટર્ન
8 Oct 2026 મુજબ
જોખમ ગુણોત્તર
30 Sep 2026 મુજબ
પોર્ટફોલિયો
30 Sep 2026 મુજબ
માર્કેટ-કેપ વિભાજન
સેક્ટર ફાળવણી
હોલ્ડિંગ્સ (83)
| હોલ્ડિંગ | ફંડનો % | મૂલ્ય | શેર |
|---|---|---|---|
| ICICI Bank Ltd. | 5.60% | ₹1,566.1 Cr | 1,18,49,171 |
| HDFC Bank Ltd. | 3.91% | ₹1,093.98 Cr | 1,54,36,415 |
| Kotak Mahindra Bank Ltd. | 3.55% | ₹994.55 Cr | 2,38,50,000 |
| Reliance Industries Ltd. | 2.42% | ₹677.31 Cr | 57,06,067 |
| State Bank of India | 2.09% | ₹585.82 Cr | 61,05,500 |
| Infosys Ltd. | 2.01% | ₹562.91 Cr | 56,62,517 |
| Sona BLW Precision Forgings Ltd. | 1.99% | ₹556.1 Cr | 67,00,000 |
| Bharat Forge Ltd. | 1.93% | ₹539.28 Cr | 28,00,000 |
| Lenskart Solutions Ltd. | 1.90% | ₹530.91 Cr | 77,50,000 |
| Mankind Pharma Ltd. | 1.85% | ₹518.88 Cr | 20,72,385 |
ફંડ વિગતો
Long term capital growth. Investments in equity and equity related securities high risk.
The fund seeks long-term growth of capital and regular income through 90% investment in equities and 10% in debt and money market securities. The scheme would adopt top-down & bottom-up approach of investing & a portion of the scheme will also be invested in IPOs, emerging sectors & other primary market offerings.
Exit load of 1%, if redeemed within 90 days.